Is there still a role for adjunctive rifampicin in S. aureus bacteraemia?

S. B. van der Meer*, C. H. S. B. van den Berg

*Corresponding author for this work

    Research output: Contribution to journalEditorialAcademicpeer-review

    Abstract

    Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. Thwaites GE, et al. Lancet. 2018 Feb 17; 391 (10121): 668-78.

    Original languageEnglish
    Pages (from-to)201-202
    Number of pages2
    JournalNetherlands Journal of Critical Care
    Volume26
    Issue number5
    Publication statusPublished - Sep-2018

    Keywords

    • staphylococcus aureus
    • s. aureus
    • bacteraemia
    • adjunctive rifampicin
    • septicaemia

    Cite this